Displaying 1-10 of 10 result(s).
| Board Name | Posts By DSherman | Post Created |
|---|---|---|
| PVSP Pervasip Corp. | I agree, I would bet you hit the 12 | 02/13/2014 1:18:52 PM |
| PVSP Pervasip Corp. | Yes, I do feel badly about that. Th | 02/11/2014 1:50:31 PM |
| PVSP Pervasip Corp. | Thank you G, I did not add yesterda | 02/06/2014 11:49:11 AM |
| PVSP Pervasip Corp. | G, I left you a pm and also sent an | 02/04/2014 8:35:52 PM |
| PVSP Pervasip Corp. | G, are you still adding? | 01/27/2014 12:36:42 PM |
| PVSP Pervasip Corp. | FYI from made on the other board. R | 01/16/2014 4:39:21 PM |
| PVSP Pervasip Corp. | Thank you for the pm. Yes, the Sain | 01/14/2014 3:37:20 PM |
| PVSP Pervasip Corp. | Ok, Thank you, just a little shell | 01/10/2014 11:09:33 AM |
| PVSP Pervasip Corp. | Thank you for your advice, I am as | 01/08/2014 1:23:15 PM |
| PVSP Pervasip Corp. | Sir, I was referred to you by a mem | 12/12/2013 3:17:49 PM |
Recent Articles
- Australia's Inflation Landscape: A Steady Shift in Core Rates
- Global Currency Trends Amid US Economic Outlook: Insights
- New Zealand Central Bank Lowers Cash Rate for Economic Boost
- China's Response to Trump's Tariff Threats Amid Fentanyl Crisis
- Hyundai Motor Receives Positive Outlook from Morgan Stanley
- Investors of China Evergrande Demand Action from Authorities
- Celsius Holdings Faces Legal Challenges Over PepsiCo Deal
- Investigation by Faruqi & Faruqi into ASML Holding after Losses
- Exploring the Future of the Peptide Synthesis Market Growth
- Investors Unite: Leading the Class Action Against Rentokil
- Investors Urged to Explore Rights in Edwards Lifesciences Case
- Investigation Underway for WM Technology Investors Due to Misrepresentation
- Investor Alert: Legal Action Regarding TMC Investigated
- Forecasting Growth in the Personalized Medicines Sector
- Argenta Silver Corp. Updates on Meeting Materials for Shareholders
- Australia's CPI Trends: Inflation Insights Amid Subsidy Support
- ASP Isotopes Faces Scrutiny After Controversial Report
- Wall Street Is Spot On About 2024 Earnings Predictions
- ATRenew Celebrates First Profit Amid Growing Trade-In Trend
- Thanksgiving 2024 Travel: A Surge in Travelers Amid Challenges
- Exploring Legal Paths for Chipotle Investors Facing Losses
- Join the $JENNER Class Action and Protect Your Investment
- Invesque Inc. Approves Major Financial Enhancements for Shareholders
- Eli Lilly & Company Experiences Significant Stock Surge Today
- Investigation Launched into ASP Isotopes Inc. and Its Practices
- JOYY Inc. Updates Their 2024 Financial Performance Insights
- China's Economic Forecast for 2025: Challenges and Opportunities
- Inflation Data: Key Focus for US Stock Market Stability Ahead
- ION Mining Launches Cutting-Edge Mobile App for Enthusiasts
- New Australian Bill Seeks to Protect Children from Social Media
- Investors Standing Against PACS Group's Alleged Misconduct
- Important SEC Class Action Deadline for PACS Group Investors
- Investors Eye Legal Actions as Xiao-I Faces Serious Allegations
- Final Approval of Settlement Marks a New Era for Realtors
- United Airlines Faces Challenges Due to Air Traffic Control Shortages
- South Korea's Pension Fund Adjusts Dollar Holdings Amid Market Changes
- NorthWest Copper Welcomes Paul Olmsted as New CEO
- Investigation Launched as Acadia Healthcare Faces Claims
- Investigation Launched for Match Group Investors Amid Significant Losses
- Navigating Market Opportunities: Strategies for Investors in 2024
- Hydreight Technologies Achieves Major Revenue Growth in Q3
- Legal Investigations Alert: Shareholder Rights and Actions
- NOVONIX Set to Shine at December Investor Engagements
- Montfort Capital Reports Q3 Financials and Divestment Plan
- Understanding Distribution Sources of Cohen & Steers Fund (RNP)
- Exploring the Innovative Landscape of Cannabis with High Science
- Understanding Cohen & Steers Total Return Realty Fund Distributions
- Investment Insights from Cohen & Steers Opportunity Fund
- Xerox Holdings Corporation: Investigating Investor Claims and Losses
- Investigation Notice: Humacyte Investors Should Act Now